Reports for SANDOZ LOSARTAN HCT
Brand name
SANDOZ LOSARTAN HCT
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02313375 |
Ingredients
HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Ingredient Strength
12.5 MG 50 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ LOSARTAN HCT | 100 | Resolved | 2019-01-22 | 2020-08-17 | 73158 |
| SANDOZ LOSARTAN HCT | 30 | Resolved | 2019-01-22 | 2020-09-15 | 73161 |
| SANDOZ LOSARTAN HCT | 100FCT BO | Resolved | 2021-09-08 | 2022-12-12 | 145343 |
| SANDOZ LOSARTAN HCT | 30FCT UD | Resolved | 2021-09-08 | 2023-05-03 | 145346 |
| SANDOZ LOSARTAN HCT | 100FCT BO | Resolved | 2023-05-01 | 2023-05-09 | 191382 |
| SANDOZ LOSARTAN HCT | 100 | Resolved | 2024-08-05 | 2024-10-01 | 234475 |
| SANDOZ LOSARTAN HCT | 30FCT | Resolved | 2024-09-03 | 2024-09-17 | 236563 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0